Safety study of HRS-1597 in healthy and obese adults
Part of Hormones & metabolism clinical trials.
This study tests the safety of a new oral medication called HRS-1597 in two groups: healthy people with normal weight and people who are overweight or obese. It will help determine if the drug is safe and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- If you are healthy and of normal weight, your body mass index (BMI) must be between 19 and 26.
- If you are overweight or obese, your BMI must be between 28 and 35.
- You must weigh at least 110 pounds if you are male, or at least 99 pounds if you are female.
- You must be willing to use highly effective birth control and not plan to have children or donate sperm/eggs for a few months after the study.
- You must not have certain medical conditions such as liver disease, diabetes, or cancer, and you must not smoke heavily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This trial tests a new injection, HEC-007, to see if it is safe in healthy adults and in people who are overweight or obese. It may help with weight management and related health issues.
This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
Hear when a new Obese and Metabolic Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.